Table:
stage of screen-detected cancer
relative risk applied to baseline survival
lead-time redistribution scalars

i
0.8
1.3

ii
1
0.4

iii
1
0.3

iv
1
0.25

Statement: lead times were estimated to be longer for cancers detected at earlier stages.
Question: which stage of screen-detected cancer were lead time estimated to be longer for cancers detected at?
Answer: i